Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Brokx S"'
Autor:
Arvinte T; Therapeomic Inc., Basel, Switzerland. Electronic address: tudor.arvinte@therapeomic.com., Poirier E; Therapeomic Inc., Basel, Switzerland., Cudd A; Therapeomic Inc., Basel, Switzerland., Ersayin N; Therapeomic Inc., Basel, Switzerland., Darpin G; Therapeomic Inc., Basel, Switzerland., Dowd J; Apobiologix, Toronto, Ontario, Canada., Brokx S; Apobiologix, Toronto, Ontario, Canada.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2024 Jan; Vol. 194, pp. 148-158. Date of Electronic Publication: 2023 Dec 12.
Autor:
Arvinte T; Therapeomic, Inc., Basel, Switzerland. Electronic address: tudor.arvinte@therapeomic.com., Poirier E; Therapeomic, Inc., Basel, Switzerland., Ersayin N; Therapeomic, Inc., Basel, Switzerland., Darpin G; Therapeomic, Inc., Basel, Switzerland., Cudd A; Therapeomic, Inc., Basel, Switzerland., Dowd J; Bayer Pharmaceuticals, Toronto, Ontario, Canada., Brokx S; NoNO, Toronto, Canada.
Publikováno v:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2023 Oct 28. Date of Electronic Publication: 2023 Oct 28.
Publikováno v:
In Journal of Microbiological Methods 2003 54(3):353-358
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
A pharmacotherapy self-assessment improves prescribing by prompting junior doctors to study further.
Autor:
van der Steen CNW; Department of Geriatric Medicine, Department of Clinical Pharmacology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., Brokx S; Maastricht University, Maastricht, the Netherlands., van den Hanenberg F; Department of Geriatric Medicine, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands., van der Stelt R; Hospital pharmacy, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., van Onzenoort-Bokken L; Department of Pediatrics, Department of Clinical Pharmacology, Máxima Medical Centre, Veldhoven, the Netherlands., Keijsers CJPW; Department of Geriatric Medicine, Department of Clinical Pharmacology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 Aug; Vol. 87 (8), pp. 3268-3278. Date of Electronic Publication: 2021 Mar 05.
Publikováno v:
Journal of Molecular Biology. 280:765-774
Jel42, Jel44 and Jel323 are mouse monoclonal antibodies specific for HPr, the histidine-containing phosphocarrier protein, of the Escherichia coli phosphoenolpyruvate:sugar phosphotransferase system. The binding constants, Kd, of the three antibodies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::709b2d2b6d2d64a4c6fc6886ca6edc15
https://doi.org/10.1006/jmbi.1998.1889
https://doi.org/10.1006/jmbi.1998.1889
Autor:
Sykes, Alison1 (AUTHOR), Ingram, Louise1 (AUTHOR), Kronthaler, Ulrich1 (AUTHOR), Chevalet, Laurent1 (AUTHOR) laurent.chevalet@fresenius-kabi.com
Publikováno v:
PLoS ONE. 10/24/2024, Vol. 19 Issue 10, p1-17. 17p.
Autor:
Arvinte T; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland; Department of Pharmaceutical Sciences, University of Geneva - University of Lausanne, Rue Michel Servet 1, 1211 Geneva, Switzerland. Electronic address: tudor.arvinte@unige.ch., Palais C; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland., Poirier E; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland., Cudd A; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland., Rajendran S; Apobiologix Inc., Toronto, Ontario, Canada., Brokx S; Apobiologix Inc., Toronto, Ontario, Canada., Dowd J; Apobiologix Inc., Toronto, Ontario, Canada.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2019 Nov 30; Vol. 176, pp. 112802. Date of Electronic Publication: 2019 Aug 10.
Autor:
Arvinte T; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland; Department of Pharmaceutical Sciences, University of Geneva - University of Lausanne, Rue Michel Servet 1, 1211 Geneva, Switzerland. Electronic address: tudor.arvinte@unige.ch., Palais C; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland., Poirier E; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland., Cudd A; Therapeomic Inc., BioPark Rosental WRO-1055, Mattenstrasse 22, 4002 Basel, Switzerland., Rajendran S; Apobiologix Inc., Toronto, Ontario, Canada., Brokx S; Apobiologix Inc., Toronto, Ontario, Canada., Dowd J; Apobiologix Inc., Toronto, Ontario, Canada.
Publikováno v:
Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2019 Oct 25; Vol. 175, pp. 112742. Date of Electronic Publication: 2019 Jul 03.
Autor:
Gibisch, Martin1 (AUTHOR), Müller, Matthias1 (AUTHOR), Tauer, Christopher1 (AUTHOR), Albrecht, Bernd2 (AUTHOR), Hahn, Rainer1 (AUTHOR), Cserjan-Puschmann, Monika1 (AUTHOR) monika.cserjan@boku.ac.at, Striedner, Gerald1 (AUTHOR)
Publikováno v:
Microbial Cell Factories. 6/5/2024, Vol. 23 Issue 1, p1-18. 18p.